title: AAN Epilepsy Quality Measures in clinical practice: a survey of neurologists.
abstract: Epilepsy Quality Measures (EQM) were developed by the American Academy of Neurology (AAN) to convey standardization and eliminate gaps and variations in the delivery of epilepsy care (Fountain et al., 2011 [1]). The aim of this study was to identify adherence to these measures and other emerging practice standards in epilepsy care. A 15-item survey was mailed to neurologists in Michigan, USA, inquiring about their practice patterns in relation to EQM. One hundred thirteen of the 792 surveyed Michigan Neurologists responded (14%). The majority (83% to 94%) addressed seizure type and frequency, reviewed EEG and MRI, and provided pregnancy counseling to women of childbearing potential. Our survey identified gaps in practice patterns such as counseling about antiepileptic drug (AED) side effects and knowledge about referral for surgical therapy of intractable epilepsy. Statistical significance in the responses on the AAN EQM was noted in relation to number of years in practice, number of epilepsy patients seen, and additional fellowship training in epilepsy. Practice patterns assessment in relation to other comorbidities revealed that although bone health and sudden unexplained death in epilepsy are addressed mainly in patients at risk, depression is infrequently discussed. The findings in this study indicate that additional educational efforts are needed to increase awareness and to improve quality of epilepsy care at various points of health care delivery.
authors: Comprehensive Epilepsy Program, Department of Neurology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA. vwasade1@hfhs.org
authors: Vibhangini S
authors: VS
authors: Wasade
authors: Marianna
authors: M
authors: Spanaki
authors: Revathi
authors: R
authors: Iyengar
authors: Gregory L
authors: GL
authors: Barkley
authors: Lonni
authors: L
authors: Schultz
mesh_terms: D000047:Academies and Institutes / Q000592:standards / Q000706:statistics & numerical data; D000927:Anticonvulsants / Q000627:therapeutic use; D004827:Epilepsy / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D006306:Health Surveys; D006801:Humans; D009462:Neurology / Q000592:standards*; D010349:Patient Compliance / Q000523:psychology; D010820:Physicians / Q000523:psychology*; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D014481:United States
chemical_list: D000927:Anticonvulsants